1921
Volume 97, Issue 1
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

Nontuberculous mycobacteria (NTM) cause significant pulmonary infections in humans. Researchers have reported an association between interferon-gamma receptor-1 (IFN-R1 or IFNGR1) deficiency and susceptibility to NTM, but the relevance of polymorphism within these genes is not yet clear. In this study, a single nucleotide polymorphism (SNP), T to C, at position-56 in NTM patients with pulmonary disease was investigated. Molecular identification of isolates was performed with genes using polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP). Then, the host genomic DNA from confirmed NTM patients ( = 80) and control subjects ( = 80) were screened for SNPs of IFNGR1 (T-56C) by PCR-RFLP. The results indicated that NTM patients had higher TC (26/80; 32.5%) or CC (46/80; 57.5%) genotypes in comparison with control groups (TC genotypes [22/80, 27.5%]; CC genotypes [6/80, 7.5%]) ( < 0.05). In this regard, all the patients infected with rapid-growing (RGM, i.e., and ) had CC genotypes (100%). In contrary, only 50.7% (35/69) of infected patients with slow-growing (i.e., , , and ) had CC genotypes. Thus, patients with CC mutation in IFNGR1 at position-56 are more likely to develop RGM infection. In overall, there is a significant association between SNP of IFNGR1 at position-56 and susceptibility to NTM infection. Based on these data, we propose SNP of IFNGR1 at position-56 as a suitable “biomarker” for identifying populations at higher risk of infection.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.16-0905
2017-07-12
2018-08-22
Loading full text...

Full text loading...

/deliver/fulltext/14761645/97/1/tpmd160905.html?itemId=/content/journals/10.4269/ajtmh.16-0905&mimeType=html&fmt=ahah

References

  1. Cassidy PM, Hedberg K, Saulson A, McNelly E, Winthrop KL, , 2009. Nontuberculous mycobacterial disease prevalence and risk factors: a changing epidemiology. Clin Infect Dis 49: 124129.[Crossref]
  2. Falkinham JO, , 2009. Surrounded by mycobacteria: nontuberculous mycobacteria in the human environment. J Appl Microbiol 107: 356367.[Crossref]
  3. Hruska K, Kaevska M, , 2012. Mycobacteria in water, soil, plants and air: a review. Vet Med (Praha) 57: 623679.
  4. Winthrop KL, Chang E, Yamashita S, Iademarco MF, LoBue PA, , 2009. Nontuberculous mycobacteria infections and anti-tumor necrosis factor-alpha therapy. Emerg Infect Dis 15: 15561561.[Crossref]
  5. Glassroth J, , 2008. Pulmonary disease due to nontuberculous mycobacteria. Chest 133: 243251.[Crossref]
  6. Johnson MM, Odell JA, , 2014. Nontuberculous mycobacterial pulmonary infections. J Thorac Dis 6: 210220.
  7. Benator DA, Gordin FM, , 1996. Nontuberculous mycobacteria in patients with human immunodeficiency virus infection. Semin Respir Infect 11: 285300.
  8. Keating MR, Daly JS; AST Infectious Diseases Community of Practice, 2013. Nontuberculous mycobacterial infections in solid organ transplantation. Am J Transplant 13: 7782.[Crossref]
  9. Velayati AA, Bakayev V, Bahadori M, Tabatabaei SJ, Alaei A, Farahbood A, Masjedi MR, , 2007. Religious and cultural traits in HIV/AIDS epidemics in sub-Saharan Africa. Arch Iran Med 10: 486497.
  10. Cooke GS, Campbell SJ, Sillah J, Gustafson P, Bah B, Sirugo G, Bennett S, McAdam KP, Sow O, Lienhardt C, Hill AV, , 2006. Polymorphism within the interferon-gamma/receptor complex is associated with pulmonary tuberculosis. Am J Respir Crit Care Med 174: 339343.[Crossref]
  11. Park HY, Kwon YS, Ki CS, Suh GY, Chung MP, Kim H, Kwon OJ, Koh WJ, , 2008. Interleukin-12 receptor beta1 polymorphisms and nontuberculous mycobacterial lung diseases. Lung 186: 241245.[Crossref]
  12. Hwang JH, Kim EJ, Koh WJ, Kim SY, Lee SH, Suh GY, Kwon OJ, Ki CS, Ji Y, Kang M, Kim DH, , 2007. Polymorphisms of interferon-gamma and interferon-gamma receptor 1 genes and non-tuberculous mycobacterial lung diseases. Tuberculosis (Edinb) 87: 166171.[Crossref]
  13. Mansouri D, Mahdaviani SA, Khalilzadeh S, Mohajerani SA, Hasanzad M, Sadr S, Nadji SA, Karimi S, Droodinia A, Rezaei N, Linka RM, Bienemann K, Borkhardt A, Masjedi MR, Velayati AA, , 2012. IL-2-inducible T-cell kinase deficiency with pulmonary manifestations due to disseminated Epstein-Barr virus infection. Int Arch Allergy Immunol 158: 418422.[Crossref]
  14. Bakayev VV, Mohammadi F, Bahadori M, Sheikholslami M, Javeri A, Masjedi MR, Velayati AA, , 2004. Arylamine N-acetyltransferase 2 slow acetylator polymorphisms in unrelated Iranian individuals. Eur J Clin Pharmacol 60: 467471.[Crossref]
  15. Varahram M, Farnia P, Nasiri MJ, Karahrudi MA, Kazempour Dizagie M, Velayati AA, , 2014. Association of Mycobacterium tuberculosis lineages with IFN-γ and TNF-α gene polymorphisms among pulmonary tuberculosis patient. Mediterr J Hematol Infect Dis 6: e2014015.[Crossref]
  16. Cooper AM, Khader SA, , 2008. The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis. Immunol Rev 226: 191204.[Crossref]
  17. Shtrichman R, Samuel CE, , 2001. The role of gamma interferon in antimicrobial immunity. Curr Opin Microbiol 4: 251259.[Crossref]
  18. Merlin G, van der Leede BJ, McKune K, Knezevic N, Bannwarth W, Romquin N, Viegas-Pequignot E, Kiefer H, Aguet M, Dembic Z, , 1997. The gene for the ligand binding chain of the human interferon gamma receptor. Immunogenetics 45: 413421.[Crossref]
  19. Le Coniat M, Alcaide-Loridan C, Fellous M, Berger R, , 1989. Human interferon gamma receptor 1 (IFNGR1) gene maps to chromosome region 6q23-6q24. Hum Genet 84: 9294.[Crossref]
  20. Wang W, Ren W, Zhang X, Liu Y, Li C, , 2014. Association between interferon gamma receptor 1-56C/T gene polymorphism and tuberculosis susceptibility: a meta-analysis. Chin Med J (Engl) 127: 37823788.
  21. Jouanguy E, Lamhamedi-Cherradi S, Altare F, Fondanèche MC, Tuerlinckx D, Blanche S, Emile JF, Gaillard JL, Schreiber R, Levin M, Fischer A, Hivroz C, Casanova JL, , 1997. Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guérin infection and a sibling with clinical tuberculosis. J Clin Invest 100: 26582664.[Crossref]
  22. Sampaio MC, Coutinho A, , 2007. Immunity to microbes: lessons from primary immunodeficiencies. Infect Immun 75: 15451555.[Crossref]
  23. Jüliger S, Bongartz M, Luty AJ, Kremsner PG, Kun JF, , 2003. Functional analysis of a promoter variant of the gene encoding the interferon-gamma receptor chain I. Immunogenetics 54: 675680.
  24. Velayati AA, Farnia P, Khalizadeh S, Farahbod AM, Hasanzadh M, Sheikolslam MF, , 2011. Interferon-gamma receptor-1 gene promoter polymorphisms and susceptibility to leprosy in children of a single family. Am J Trop Med Hyg 84: 627629.[Crossref]
  25. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, Iseman M, Olivier K, Ruoss S, von Reyn CF, Wallace RJ, Jr Winthrop K, ATS Mycobacterial Diseases Subcommittee; American Thoracic Society; Infectious Disease Society of America, 2007. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175: 367416.[Crossref]
  26. Miller SA, Dykes DD, Polesky HF, , 1989. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16: 1215.[Crossref]
  27. Telenti A, Marchesi F, Balz M, Bally F, Böttger EC, Bodmer T, , 1993. Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis. J Clin Microbiol 31: 175178.
  28. Velayati AA, Farnia P, Mozafari M, Malekshahian D, Seif S, Rahideh S, Mirsaeidi M, , 2014. Molecular epidemiology of nontuberculous mycobacteria isolates from clinical and environmental sources of a metropolitan city. PLoS One 9: e114428.[Crossref]
  29. Thye T, Burchard GD, Nilius M, Müller-Myhsok B, Horstmann RD, , 2003. Genome wide linkage analysis identifies polymorphism in the human interferon-gamma receptor affecting Helicobacter pylori infection. Am J Hum Genet 72: 448453.[Crossref]
  30. Kardum LB, Etokebe GE, Knezevic J, , 2005. Interferon-γ receptor-1 gene promoter polymorphisms (G 611A; T-56C) and susceptibility to tuberculosis. Scand J Immunol 63: 142150.[Crossref]
  31. Newport MJ, Huxley CM, Huston S, Hawrylowicz CM, Oostra BA, Williamson R, Levin M, , 1996. A mutation in the interferon-γ receptor gene and susceptibility to mycobacterial infection. N Engl J Med 335: 19411948.[Crossref]
  32. Levin M, Newport MJ, Kalabalikis P, Brown IN, Lenicker HM, Agius PV, Davies EG, Thrasher A, Klein N, Blackwell JM, , D’Souza S, , 1995. Familial disseminated atypical mycobacterial infection in childhood: a human mycobacterial susceptibility gene? Lancet 345: 7983.[Crossref]
  33. Bellamy R, , 2003. Susceptibility to mycobacterial infections: the importance of host genetics. Genes Immun 23: 411.[Crossref]
  34. Guide SV, Holland SM, , 2002. Host susceptibility factors in mycobacterial infection. Genetics and body morphotype. Infect Dis Clin North Am 16: 163186.[Crossref]
  35. Dorman SE, Holland SM, , 1998. Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection. J Clin Invest 101: 23642369.[Crossref]
  36. Altare F, Jouanguy E, Lamhamedi-Cherradi S, Fondanéche MC, Fizame C, Ribiérre F, Merlin G, Dembic Z, Schreiber R, Lisowska-Grospierre B, Fischer A, Seboun E, Casanova JL, , 1998. A causative relationship between mutant IFNgR1 alleles and impaired cellular response to IFNγ in a compound heterozygous child. Am J Hum Genet 62: 723726.[Crossref]
  37. Dupuis S, Döffinger R, Picard C, Fieschi C, Altare F, Jouanguy E, Abel L, Casanova JL, , 2000. Human interferon-γ-mediated immunity is a genetically controlled continuous trait that determines the outcome of mycobacterial invasion. Immunol Rev 178: 129137.[Crossref]
  38. Lake MA, Ambrose LR, Lipman M C I, Lowe DM, , 2016. “Why me, why now?” Using clinical immunology and epidemiology to explain who gets nontuberculous mycobacterial infection. BMC Med 14: 54.[Crossref]
  39. Mirsaeidi M, Farshidpour M, Allen MB, Ebrahimi G, Falkinham JO, , 2014. Highlight on advances in nontuberculous mycobacterial disease in North America. Biomed Res Int 2014: 919474.[Crossref]
  40. Biranvand E, Abedian Kenary S, Ghaheri A, Rezaei MS, Hasannia H, Nasrolahi M, Parsaee MR, Ahanjan M, Biranvand B, Ahmadi Basiri E, Jivad F, , 2011. Interferon-gamma gene polymorphism in patients with tuberculosis. Med Lab J 5: 1823.
  41. Baghaei P, Tabarsi P, Farnia P, Marjani M, Sheikholeslami FM, Chitsaz M, Gorji Bayani P, Shamaei M, Mansouri D, Masjedi MR, Velayati AA, , 2012. Pulmonary disease caused by Mycobacterium simiae in Iran’s national referral center for tuberculosis. J Infect Dev Ctries 6: 2328.[Crossref]
  42. Velayati AA, Farnia P, Mozafari M, Mirsaeidi M, , 2015. Nontuberculous mycobacteria isolation from clinical and environmental samples in Iran: twenty years of surveillance. BioMed Res Int 2015: 254285.[Crossref]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.16-0905
Loading
/content/journals/10.4269/ajtmh.16-0905
Loading

Data & Media loading...

  • Received : 16 Nov 2016
  • Accepted : 03 Feb 2017

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error